Taken together, our findings evidence that PI3K/Akt/mTOR inhibitors, in particular, mTOR inhibitors, are potentially able to revert the expression of the genes associated with the response to hypoxia in NB tumors. This evidence concerns the gene AKT1 and neuroblastoma.